RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Strategy: Current Global Regulatory Strategies: The Convergence of Opportunities, Challe

Regulatory Strategy: Current Global Regulatory Strategies: The Convergence of Opportunities, Challenges and Ethics

Posted 01 November 2009

The past few years have seen the rise of several distinct, yet additive elements that impact the effectiveness of a global regulatory strategy for marketing new drug products. These include a clinical and regulatory focus on personalized medicine, as well as recognition of the growing opportunities for developing innovative products in emerging global markets. Awareness of the need to implement strategies that extend beyond the traditional steps historically required that demonstrate a drug's safety, efficacy and positive benefit-to-risk prior to receiving marketing authorization is becoming necessary. These new challenges and opportunities are the result of the rapidly changing global environment, which is being shaped by new, innovative science, emerging socioeconomic regions and multiple intrinsic and extrinsic aspects such as product safety, benefit-to-risk, branding and reimbursement, all working in concert to reshape the regulatory environment.

 

© 2022 Regulatory Affairs Professionals Society.